Catalyst Wire Dossier Catalyst Wire Dossier

rhGH and rhIGF-1 combination therapy

· Ipsen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhGH and rhIGF-1 combination therapy, covering 2015-12-15 to 2015-12-15. Get the full timeline:

Most recent: Clinical Trial Update: rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency [Phase 2]

See pricing